theratype Logo (EUIPO, 07/02/2019)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark theratype was filed as Figurative mark on 07/02/2019 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/28/2022.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Imprints of hands or of fingers #Letters containing written or typographical matter #Letters overlapping #Letter 'T'
| Trademark form | Figurative mark |
| File reference | 018089239 |
| Application date | July 2, 2019 |
| Publication date | August 7, 2019 |
| Entry date | June 28, 2022 |
| Expiration date | July 2, 2029 |
Trademark owner
Ingolstädter Landstraße 1
85764 Neuherberg
DE
85764 Neuherberg
DE
Trademark representatives
Ganghoferstrasse 68b
80339 München
DE
Objection / Complaint
goods and services
1
Chemicals for use in industry and science, In particular reagents for the imaging analysis of biological tissues, in particular human tissue, animal tissue, including insect tissue, and plant tissue; Reagents for investigations relating to physiological and pathophysiological processes and diseases that manifest in tissue, in particular cancer, inflammatory diseases and degenerative diseases, including immune system diseases and neurodegenerative diseases; Reagents for investigations relating to physiological and pathophysiological processes and diseases by means of imaging microscopy and/or imaging mass spectrometry (MALDI imaging); Analysis kits for use in industry and science for the imaging analysis of biological tissues, in particular human tissue, animal tissue, including insect tissue, and plant tissue, consisting predominantly of chemical reagents; Analysis kits for investigations in relation to physiological and pathophysiological processes and diseases that manifest in tissue, in particular cancer, inflammatory diseases and degenerative diseases, including immune system diseases and neurodegenerative diseases; Analysis kits for investigations in relation to physiological and pathophysiological processes and diseases by means of imaging microscopy and/or imagine mass spectrometry; Diagnostic agents, not for medical purposes
5
Diagnostics, for medical and veterinary purposes
42
Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; Biochemical or pharmaceutical laboratory services, in particular in the field of diagnosing and treating physiological and pathophysiological processes and diseases that manifest in tissue, in particular cancer, inflammatory diseases and degenerative diseases, including immune system diseases and neurodegenerative diseases; Diagnosis and treatment of physiological and pathophysiological processes and diseases by means of imaging microscopy and/or imaging mass spectrometry; Active ingredient analysis; Treatment prediction and diagnostics in the field of medicine and veterinary medicine; Design and development of software for diagnosing and treating physiological and pathophysiological processes and diseases
ID: 11018089239